Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aki Furusawa

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Cancer Letters|July 9, 2025
Preserved host immunity with intercellular adhesion molecule-1 (ICAM-1)-targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of triple-negative breast cancer and other malignanciesSeiichiro Takao, Hideyuki Furumoto, Aki Furusawa, et al.
Pharmaceutics|October 27, 2022
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal OriginFuyuki F Inagaki, Takuya Kato, Aki Furusawa, et al.
Molecular Cancer Therapeutics|October 12, 2022
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated FibroblastsTakuya Kato, Aki Furusawa, Ryuhei Okada, et al.
Cancer Immunology Research|January 19, 2020
Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer ModelsYasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, et al.
Journal of the American Chemical Society|June 13, 2022
Cyanine Phototruncation Enables Spatiotemporal Cell LabelingHiroshi Fukushima, Siddharth S Matikonda, Syed Muhammad Usama, et al.
Oncoimmunology|January 10, 2022
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma modelAki Furusawa, Ryuhei Okada, Fuyuki Inagaki, et al.
Oncoimmunology|December 5, 2022
Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune responseTakuya Kato, Hiroshi Fukushima, Aki Furusawa, et al.
Cancer Science|June 8, 2021
Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer modelRyuhei Okada, Aki Furusawa, Fuyuki Inagaki, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine GreenShuhei Okuyama, Daiki Fujimura, Fuyuki Inagaki, et al.
Molecular Cancer Therapeutics|September 14, 2021
Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse ModelsTakuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Cancer Letters|July 9, 2025
Preserved host immunity with intercellular adhesion molecule-1 (ICAM-1)-targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of triple-negative breast cancer and other malignanciesSeiichiro Takao, Hideyuki Furumoto, Aki Furusawa, et al.
Pharmaceutics|October 27, 2022
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal OriginFuyuki F Inagaki, Takuya Kato, Aki Furusawa, et al.
Molecular Cancer Therapeutics|October 12, 2022
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated FibroblastsTakuya Kato, Aki Furusawa, Ryuhei Okada, et al.
Cancer Immunology Research|January 19, 2020
Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer ModelsYasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, et al.
Journal of the American Chemical Society|June 13, 2022
Cyanine Phototruncation Enables Spatiotemporal Cell LabelingHiroshi Fukushima, Siddharth S Matikonda, Syed Muhammad Usama, et al.
Oncoimmunology|January 10, 2022
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma modelAki Furusawa, Ryuhei Okada, Fuyuki Inagaki, et al.
Oncoimmunology|December 5, 2022
Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune responseTakuya Kato, Hiroshi Fukushima, Aki Furusawa, et al.
Cancer Science|June 8, 2021
Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer modelRyuhei Okada, Aki Furusawa, Fuyuki Inagaki, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine GreenShuhei Okuyama, Daiki Fujimura, Fuyuki Inagaki, et al.
Molecular Cancer Therapeutics|September 14, 2021
Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse ModelsTakuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Pageof 7